Abstract
Blood flow is essential for human to maintain the life and also a very important biosample for physicians and clinical researchers to observe the condition of the human body. The reasons why investigating human serum is important are as follows: (1) human serum is easy to collect, (2) human serum contains various chemicals or biomarkers suitable for diagnosis, and (3) huge quantities of clinical test protocols using serum are already established and even automated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ikemoto M, Tsunekawa S, Tanaka K, et al. Liver-type l-arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta. 1998;271:11–23.
Ikemoto M, Ishida A, Tsunekawa S, et al. Enzyme immunoassay of liver-type l-arginase and its potential clinical application. Clin Chem. 1993;39:794–9.
Durante W, Johnson FK, Johnson RA. l-Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34:906–11.
Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91–5.
Geyer JW, Dabich D. Rapid method for determination of l-arginase activity in tissue homogenates. Anal Biochem. 1971;39:412–7.
Xu W, Kaneko FT, Zheng S, et al. Increased l-arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J. 2004;18:1746–8.
Wang SR, Chen ML, Huang MH, et al. Plasma l-arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population. Clin Biochem. 1993;26:455–60.
Kimura M, Tatsumi KI, Tada H, et al. Enzyme immunoassay for autoantibodies to human liver-type l-arginase and its clinical application. Clin Chem. 2000;46:112–7.
Huang LW, Liu HW, Chang KL. Development of a sandwich ELISA test for l-arginase measurement based on monoclonal antibodies. Hybridoma. 2001;20:53–7.
Ikemoto M, Tsunekawa S, Awane M, et al. A useful ELISA system for human liver-type l-arginase, and its utility in diagnosis of liver diseases. Clin Biochem. 2001;34:455–61.
Ogino K, Murakami I, Wang DH, et al. Evaluation of serum l-arginase I as an oxidative stress biomarker in a healthy Japanese population using a newly established ELISA. Clin Biochem. 2013;46:1717–22.
Vilas-Boas W, Cerqueira BA, Zanette AM, et al. l-Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients. Ann Hematol. 2010;89:877–82.
Kim PS, Iyer RK, Lu KV, et al. Expression of the liver form of l-arginase in erythrocytes. Mol Genet Metab. 2002;76:100–10.
Morris CR, Suh JH, Hagar W, et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008;111:402–10.
Eleftheriadis T, Liakopoulos V, Antoniadi G, et al. l-Arginase type I as a marker of coronary heart disease in hemodialysis patients. Int Urol Nephrol. 2011;43:1187–94.
Ogino K, Takahashi N, Takigawa T, et al. Association of serum l-arginase I with oxidative stress in a healthy population. Free Radic Res. 2011;45:147–55.
Ogino K, Obase Y, Takahashi N, et al. High serum l-arginase I levels in asthma: its correlation with high-sensitivity C-reactive protein. J Asthma. 2011;48:1–7.
Bekpinar S, Gurdol F, Unlucerci Y, et al. Serum levels of l-arginase I are associated with left ventricular function after myocardial infarction. Clin Biochem. 2011;44:1090–3.
El-Hady SB, Farahat MH, Atfy M, et al. Nitric oxide metabolites and l-arginase I levels in β-thalassemic patients: an Egyptian study. Ann Hematol. 2012;91:1193–200.
Ogino K, Wang DH, Kubo M, et al. Association of serum l-arginase I with l-arginine, 3-nitrotyrosine, and exhaled nitric oxide in healthy Japanese workers. Free Radic Res. 2014;48:137–45.
Choudhury B, Srivastava S, Choudhury HH, et al. l-Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India. Tumour Biol. 2014;35:6739–48.
Polat MF, Taysi S, Polat S, et al. Elevated serum l-arginase activity levels in patients with breast cancer. Surg Today. 2003;33:655–61.
Porembska Z, Skwarek A, Mielczarek M, et al. Serum l-arginase activity in postsurgical monitoring of patients with colorectal carcinoma. Cancer. 2002;94:2930–4.
Elgün S, Keskineğe A, Yilmaz E, et al. Evaluation of serum l-arginase activity in benign prostatic hypertrophy and prostatic cancer. Int Urol Nephrol. 1999;31:95–9.
Elgün S, Kumbasar H. Increased serum l-arginase activity in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:227–32.
Chrzanowska A, Graboń W, Mielczarek-Puta M, et al. Significance of l-arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment. Clin Biochem. 2014;47:1056–9.
Graboń W, Mielczarek-Puta M, Chrzanowska A, Barańczyk-Kuźma A. l-arginine as a factor increasing l-arginase significance in diagnosis of primary and metastatic colorectal cancer. Clin Biochem. 2009;42:353–7.
Porembska Z, Luboiński G, Chrzanowska A, et al. l-Arginase in patients with breast cancer. Clin Chim Acta. 2003;328:105–11.
del Ara RM, González-Polo RA, Caro A, et al. Diagnostic performance of l-arginase activity in colorectal cancer. Clin Exp Med. 2002;2:53–7.
Tektaş AK, Uslu S, Yalçin AU, et al. Effects of lipoprotein-associated phospholipase A2 on l-arginase/nitric oxide pathway in hemodialysis patients. Ren Fail. 2012;34:738–43.
Kocyigit A, Zeyrek D, Keles H, et al. Relationship among manganese, l-arginase, and nitric oxide in childhood asthma. Biol Trace Elem Res. 2004;102:11–8.
The Human Cytochrome P450 (CYP) Allele Nomenclature Database. http://www.cypalleles.ki.se/. Accessed 26 Sept 2014.
Kline JA, Watts J, Courtney D, et al. Severe pulmonary embolism decreases plasma l-arginine. Eur Respir J. 2014;43:906–9.
Morris Jr SM. Recent advances in l-arginine metabolism: roles and regulation of the l-arginases. Br J Pharmacol. 2009;157:922–30.
Yang BK, Vivas EX, Reiter CD, et al. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res. 2003;37:1–10.
Taddei S, Virdis A, Mattei P, et al. Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298–303.
Schulman SP, Becker LC, Kass DA, et al. l-arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ogino, K., Takemoto, K. (2017). Serum l-Arginase in Healthy Subjects and Nitric Oxide. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_14
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)